Pharmacometabonomics as an Effector for Personalized Medicine
Year: 2010
Type: review
Source: Pharmacogenomics
DOI: 10.2217/pgs.10.157
Institutions: AstraZeneca (United Kingdom), Imperial College London
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
Funders: Pfizer, Imperial College London
OpenAlex ID: W2136780652
